← Back to Search

Cognitive Behavioral Therapy App for Cancer Pain (STAMP+CBT Trial)

N/A
Recruiting
Led By Desiree Azizoddin, PsyD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has an active prescription for at least one opioid medication to treat their cancer pain (i.e. not for post-surgical pain)
Chronic pain related to cancer or treatment (> pain score of 4)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-weeks
Awards & highlights

STAMP+CBT Trial Summary

This trial aims to create a tech app to help people with advanced cancer track pain, mood, opioids, side effects & get tailored advice.

Who is the study for?
This trial is for adults over 18 with advanced cancer experiencing chronic pain (pain score >4) and using opioids to manage it. They must be undergoing treatment or receiving supportive care, not in remission, hospice, or hospitalized. Excludes those with cognitive impairments affecting participation, non-English speakers, recent surgery patients, and individuals under opioid risk mitigation programs.Check my eligibility
What is being tested?
The study tests a new smartphone app called STAMP+CBT designed to help track pain levels, mood changes, opioid use and side effects while providing personalized education and self-management tips for managing cancer-related pain.See study design
What are the potential side effects?
Since this intervention involves Cognitive Behavioral Therapy via an app rather than medication or invasive procedures, the side effects are minimal but may include discomfort from confronting painful emotions or stress related to tracking one's condition.

STAMP+CBT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently prescribed opioids for my cancer pain.
Select...
My cancer or its treatment causes me significant pain.
Select...
I am 18 years old or older.

STAMP+CBT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients who complete more than 2/3rd of the study modules at the end of 4 weeks of intervention to determine feasibility of the STAMP+CBT app
Proportion of patients who rate the acceptability items 4 or higher on the app.

STAMP+CBT Trial Design

1Treatment groups
Experimental Treatment
Group I: STAMP+CBT appExperimental Treatment1 Intervention
This app will allow the patient to access daily surveys designed to assess pain, stress, mood, and related symptoms. Based on patient-reported symptoms, this app will disseminate tailored education to manage the symptoms.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,863 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,672 Previous Clinical Trials
40,926,381 Total Patients Enrolled
Desiree Azizoddin, PsyDPrincipal InvestigatorStephenson Cancer Center
1 Previous Clinical Trials
15 Total Patients Enrolled

Media Library

Cognitive Behavioral Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05774197 — N/A
Opioid Use Disorder Research Study Groups: STAMP+CBT app
Opioid Use Disorder Clinical Trial 2023: Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT05774197 — N/A
Cognitive Behavioral Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05774197 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still open for this experiment?

"The clinicaltrials.gov archive states that this medical trial has not been actively recruiting since the last update on March 16th of 2023. However, there are currently 171 other trials available for recruitment at this time."

Answered by AI
~5 spots leftby Jun 2024